Neurologia i Neurochirurgia Polska

Papers
(The TQCC of Neurologia i Neurochirurgia Polska is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns33
Early post-stroke rehabilitation for upper limb motor function using virtual reality and exoskeleton: equally efficient in older patients33
Pediatric multiple sclerosis – current status of epidemiology, diagnosis and treatment28
COVID-19-related headache and innate immune response — a narrative review25
Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience23
The role of fibrinogen in acute ischaemic stroke20
Nusinersen treatment of Spinal Muscular Atrophy Type 1 — results of expanded access programme in Poland18
Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)18
Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome17
Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome15
Prevalence of cognitive impairment in acute ischaemic stroke and use of Alberta Stroke Programme Early CT Score (ASPECTS) for early prediction of post-stroke cognitive impairment15
COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish14
Cannabis and cannabinoids: pharmacology and therapeutic potential13
Neurological and neurourological complications of electrical injuries13
Pneumocephalus as a rare complication: a systematic review plus clinical vignette11
Trends in glioblastoma treatment research: an analysis of clinical trials and literature11
Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality11
First Polish case of CSF1R-related leukoencephalopathy11
Genetics of Parkinson’s disease in the Polish population11
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with an A792D mutation in the CSF1R gene in a Polish patient10
Changes in cervical range of motion following anterior cervical discectomy with fusion — preliminary results10
Botulinum toxin type-A preparations are not the same medications — basic science (Part 1)10
Use of cannabidiol in the treatment of epilepsy10
Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus10
Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue9
Vigabatrin — new data on indications and safety in paediatric epilepsy9
Cannabis in Parkinson’s Disease — the patient’s perspective versus clinical trials: a systematic literature review9
Variability in melatonin concentration in blood serum of patients with episodic migraine: a pilot study8
Post-COVID 19 Neurological Syndrome: a fresh challenge in neurological management8
Blood-brain barrier function in response to SARS-CoV-2 and its spike protein8
D-penicillamine-induced lupus erythematosus as an adverse reaction of treatment of Wilson’s Disease8
Nucleus accumbens as a stereotactic target for the treatment of addictions in humans: a literature review8
Spontaneous spinal epidural haematoma: management and main risk factors in era of anticoagulant / antiplatelet treatment8
Effects of sex and APOE on Parkinson’s Disease-related cognitive decline7
Neuro-COVID-19: an insidious virus in action7
Alzheimer’s disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities7
Association between intention to call EMS in stroke patients and level of hospital classification and emergency medical service usage among stroke patients in China7
Immunosenescence and multiple sclerosis6
Factors that may delay disappearance of trigeminal neuralgia after percutaneous balloon compression6
The assessment of cognitive and behavioural disturbances in vascular cognitive impairment (VCI) — recommendations of an expert working group6
Role of DTI-MRI parameters in diagnosis of ALS: useful biomarkers for daily practice? Tertiary centre experience and literature review6
Cerebral microbleeds in neurological practice: concepts, diagnostics and clinical aspects6
Structural brain assessment of temporal lobe epilepsy based on voxel-based and surface-based morphological features6
Impact of SARS-CoV-2 on the nervous system6
Importance of non-motor symptoms in PD and atypical parkinsonism6
Impact of COVID-19 on incidence and treatment of intracranial aneurysms in Poland: a national study6
Predictors of cognitive impairment in pseudotumor cerebri6
COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study6
Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy — an evidence-based review6
Relationship between blood-brain permeability and antibodies against aquaporins in neuromyelitis optica spectrum disorders and multiple sclerosis patients5
Transvenous embolisation via an occluded inferior petrosal sinus for cavernous sinus dural arteriovenous fistulas5
Multiple sclerosis immunomodulatory therapies tested for effectiveness in COVID-195
Bed regime as a lifesaving factor in spontaneous intracranial hypotension5
Botulinum neurotoxin in cervical dystonia revisited — recent advances and unanswered questions5
Predictors of outcome events and 6-year mortality after carotid endarterectomy and carotid stenting in patients with carotid artery stenosis5
YouTube as a source of patient information on brain aneurysms: a content-quality and audience engagement analysis5
Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases5
Screening and diagnosis for mood and anxiety disorders in epilepsy: Polish population reference values4
Double vision in Parkinson’s Disease: a systematic review4
LRRK2 R1441C mutation causing Parkinson’s Disease in an Egyptian family4
Migraine treatment recommendations developed by an Expert Group of the Polish Headache Society, the Headache Section of the Polish Neurological Society, and the Polish Pain Society4
Potential use of glucocorticosteroids in CSF1R mutation carriers – current evidence and future directions4
Facial onset sensory and motor neuronopathy syndrome — a rare variant of motor neurone disease4
Movement disorders associated with chromosomal aberrations diagnosed in adult patients4
Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS)4
Reliability of prehospital diagnosis of acute cerebrovascular accident4
Is deep brain stimulation effective in Huntington’s Disease? — a systematic literature review4
EasyGO!-assisted microsurgical anterior cervical decompression: technical report and literature review4
Associations of optical coherence tomography with disability and brain MRI volumetry in patients with multiple sclerosis4
Mechanical thrombectomy for acute ischaemic stroke during therapeutic anticoagulation: long-term outcomes4
Fluoxetine for stroke recovery improvement – the doubleblind, randomised placebo-controlled FOCUS-Poland trial4
Acute-onset chorea and confusional state in 77-year-old COVID-19 patient: a case report4
Diagnostic value of diffusion tensor imaging in patients with clinical signs of cervical spondylotic myelopathy4
Cardiovascular dysautonomia and cognition in Parkinson’s Disease — a possible relationship3
Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study3
Ruptured temporal horn aneurysm associated with Moyamoya collateral vessel coexisting with contralateral arteriovenous malformation — technical note with clinical vignette3
Migraine diagnosis and treatment in Poland: survey of primary care practitioners3
Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection — a systematic review3
Update on pathology of central nervous system inflammatory demyelinating diseases3
COVID-19 and autoimmune diseases of the nervous system — an update3
Cross-circulation thrombectomy through posterior communicating artery for acute middle cerebral artery occlusion using Solitaire FR stent with intermediate catheter assisting technique3
Targeting CD20 in multiple sclerosis — review of current treatment strategies3
B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic — when immunosuppression meets infection?3
Botulinum toxin type A for hand tremor: a meta-analysis of randomised controlled trials3
Fronto-orbito-zygomatic (FOZ) approach for infratemporal fossa lesions extending to middle cranial fossa: our experience and review of literature3
Incidence of dystonia related to COVID-19 infection3
Could hyperlipidemia be a risk factor for corticobasal syndrome? — a pilot study3
Battery for deep brain stimulation depletion in Parkinson’s Disease and dystonia patients — a systematic review3
Hypertrophic pachymeningitis associated with Sjögren’s syndrome: case report and literature review3
Lacosamide and myoclonic seizures: what is the risk of aggravation?3
Capgras syndrome in dementia with Lewy bodies: a possible association of severe cortical Lewy body pathology3
The relation between plasma miR-126 levels and cerebral collateral circulation in patients with intracranial arterial stenosis3
Botulinum toxin type-A preparations are not the same medications — clinical studies (Part 2)3
Mechanical thrombectomy in COVID-19-associated ischaemic stroke: patient characteristics and outcomes in a single-centre study3
Prevalence of polyneuropathies among systemic sclerosis patients and impact on health-related quality of life3
0.037683010101318